ARC-T

Serial Number 87909808
606

Registration Progress

Application Filed
May 7, 2018
Under Examination
Nov 27, 2018
Approved for Publication
Oct 2, 2018
Published for Opposition
Oct 2, 2018
Registered

Trademark Image

ARC-T

Basic Information

Serial Number
87909808
Filing Date
May 7, 2018
Published for Opposition
October 2, 2018
Abandonment Date
January 3, 2022
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jan 3, 2022
Classes
005

Rights Holder

Arcellx, Inc.

03
Address
800 Bridge Pkwy
Redwood City, CA 94065

Ownership History

Arcellx, Inc.

Original Applicant
03
Germantown, MD

Arcellx, Inc.

Owner at Publication
03
Redwood City, CA

Legal Representation

Attorney
Aaron D. Hendelman

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

41 events
Date Code Type Description Documents
Feb 13, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Feb 13, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Feb 13, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jul 7, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jul 7, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jul 7, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jan 3, 2022 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Jan 3, 2022 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
May 7, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 6, 2021 EX5G S SOU EXTENSION 5 GRANTED Loading...
May 6, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Apr 27, 2021 EXT5 S SOU EXTENSION 5 FILED Loading...
Apr 27, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 20, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 18, 2020 EX4G S SOU EXTENSION 4 GRANTED Loading...
Nov 18, 2020 EXT4 S SOU EXTENSION 4 FILED Loading...
Nov 18, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 23, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 21, 2020 EX3G S SOU EXTENSION 3 GRANTED Loading...
May 21, 2020 EXT3 S SOU EXTENSION 3 FILED Loading...
May 21, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 22, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 20, 2019 EX2G S SOU EXTENSION 2 GRANTED Loading...
Nov 20, 2019 EXT2 S SOU EXTENSION 2 FILED Loading...
Nov 20, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 15, 2019 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Oct 15, 2019 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Oct 15, 2019 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Oct 15, 2019 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
May 7, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 3, 2019 EX1G S SOU EXTENSION 1 GRANTED Loading...
May 3, 2019 EXT1 S SOU EXTENSION 1 FILED Loading...
May 3, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 27, 2018 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 2, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 2, 2018 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 12, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 29, 2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 28, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
May 16, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 10, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Biological preparations for the treatment of cancer using polypeptides and genetically engineered cells; pharmaceutical preparations for targeting tissues based on select tissue markers and ligands; pharmaceutical preparations for the purpose of binding ligands using engineered polypeptides and receptors; pharmaceutical preparations for immunotherapy using polypeptides and genetically engineered cells; pharmaceutical preparations for immune cell therapy using polypeptides and genetically engineered cells

Classification

International Classes
005